Breadcrumb

Breadcrumbs

Media Contacts Main Article

Media Contacts

Resources to Help You Get Answers

For global Media & Investor Relations materials, please click here.

U.S. Public Affairs/Corporate Communications
publicaffairs@dsi.com

For cardiovascular products and Corporate Communications:
Kim Wix, Senior Director
U.S. Public Affairs
973-944-2338
kwix@dsi.com

For oncology products:
Jennifer Brennan
Director, Global Product Communications
U.S. Public Affairs
973-944-2393
Mobile +1 201 709 9309
jbrennan2@dsi.com

For pain products:
Alyssa Dargento, Director
U.S. Public Affairs
973-944-2913
adargento@dsi.com

Reporting Adverse Reactions

Please report any adverse reactions to our products to the Daiichi Sankyo Contact Center at 1-877-4 DS-PROD (1-877-437-7763). Or to report negative side effects of prescription drugs to the FDA visit www.fda.gov/medwatch

Media Contacts More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability…

read more ...